AnHui HaiKang Pharmaceutical CO.,LTD

Tofacitinib, a JAK inhibitor developed by Pfizer, effectively inhibits the activity of JAK1 and JAK3 and blocks the signal transduction of many inflammatory cytokines. Existing research shows that tofacitinib has a good therapeutic effect on various inflammation-related diseases such as rheumatoid arthritis, ulcerative colitis and psoriasis.

CAS number: 540737-29-9

English name: Tofacitinib citrate

English Synonyms: Xeljanz; CP 690500-10; CP 690550-10; Tofacitinib API; CP-690550 citrate; Tasocitinib citrate; Tofacitinib citrate; Tofacitinib Citratet; Tofacititinib cirate; Xeljanz (tofacitinib)

Chinese name: Tofatinib citrate

Chinese Synonyms: tofacitinib citrate; tofacitinib wolfberry; tofacitinib citrate; tofacitinib raw drug; tolofibrate citrate; tofacitinib impurities 43; citric acid Tofacitinib (API); CP 690550 citrate; tofacibit citrate / tofacitinib citrate; tofacitinib BASE, oily, unstable

CBNumber: CB92460269

Molecular formula: C16H20N6O.C6H8O7

Molecular weight: 504.497

MOL File: 540737-29-9.mol